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Background
Previous studies have suggested that hypertensive patients
with type 2 diabetes mellitus could lead to learning and
memory deficits especially after stroke. Mini Mental State
Examination (MMSE) is the most common cognitive
function test which has been used to evaluate the degree
of cognitive dysfunction. The subjects diagnosed with
stroke are usually submitted to brain CT. The aim of our
study was to correlate clinical and imaging findings in
after stroke patients.
Materials and methods
22 patients mean age 77 ± 5 years old, having history of
arterial hypertension and type 2 diabetes mellitus were
admitted to our clinic for an ischemic stroke. According to
MMSE scores patients were classified to four categories: A)
0–10: severe cognitive dysfunction, B) 11–20: moderate
cognitive dysfunction, C) 21–27: mild to possible, D) 28–
30: absence of cognitive dysfunction. Radiological criteria
of dementia such as brain atrophy, dilatation of the ven-
tricles, porencephalia and enlargement of scissures were
searched. Arterial blood pressure, blood glucose levels,
cholesterol, triglyceride, HDL and uric acid were meas-
ured.
Results
1. See Table 1.
2. See Table 2.
3. a. Mean arterial blood pressure: SBP: 169.6 ± 22.9, DBP:
85.3 ± 22.8, b. Uric acid: 5.49 ± 2 mg/dl, c. total choles-
terol: 201.4 ± 48.7 mg/dl, d. HDL: 50.6 ± 17.2 mg/dl, trig-
lycerides: 144.2 ± 59 mg/dl, e. glucose: 140.7 ± 57, 3 mg/
dl.
Discussion
1) The cognitive dysfunction even dementia is correlated
with findings of brain atrophy while only the later can not
constitute a safe indicator for the diagnosis of dementia.
2) The possibility of CT findings of brain atrophy
increases significantly when the MMSE score decreases. 3)
Arterial hypertension and diabetes mellitus seem to
remain the main risk factors even under medications
while the new ones such as elevated uric acid and triglyc-
erides, as constituents of the metabolic syndrome, are
found within the normal limits.
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Table 1: Classification of patients according to MMSE score






Table 2: CT results in each group
MMSE score Patients Findings in CT-scan
Brain atrophy Without Brain Atrophy
0–10 3 3 i.i.* 0 i.i.
11–20 9 8 i.i. 1 i.i.
21–24 3 2 i.i. 1 i.i.
25–27 5 2 i i. 1 i.i.
28–30 2 2 i.i. 0 i.i.
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